Checkpoint Therapeutics
Price & Volume
Stats
See moreOpen | $2.55 |
Previous Close | $2.46 |
Day Range | $2.44-$2.60 |
52W Range | $1.30-$3.62 |
Market Cap | $113.4M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $78,000 |
Revenue Growth (YoY) | 32.3% |
Gross Profit (12 Mos) | -$48.1M |
Diluted EPS | -$1.71 |
News
See moreYahoo Finance • 10 months ago
Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
Yahoo Finance • 11 months ago
Checkpoint Therapeutics Announces Publication of Cosibelimab Pivotal Trial Results in the Journal for ImmunoTherapy of Cancer
Yahoo Finance • 12 months ago
Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds
Yahoo Finance • last year
Checkpoint Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
About
CEO | Mr. James F. Oliviero III, C.F.A. |
CFO | Mr. William Garrett Gray |
Address | 95 Sawyer Road, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
